Clinical Trials in Houston

Showing 8201-8220 of 13,620 trials

Transvenous Lead Removal Post-Market Clinical Study

NCT03688412

This prospective, multicenter, post-market clinical study was designed to evaluate the outcomes of lead extraction of cardiovascular implantable electronic devices (CIED) using Cook catheter and lead extraction devices for any indication it is used in the commercial setting within the United States and Europe. The purpose of this clinical study is to collect data on the performance of the Cook lead extraction devices for the purpose of supporting publications and presentations

Cardiac Electrophysiology

Cook Research Incorporated230 participantsStarted Oct 2018

San Francisco, California, United States • Urbana, Illinois, United States • Raleigh, North Carolina, United States +6 more locations

COMPLETEDPhase 2< 1 mile

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

NCT02187302

This study to evaluate treatment in patients with metastatic renal cell carcinoma (RCC) which has progressed through 2 to 3 prior lines of therapy, with the investigational drug CRLX101 in combination with bevacizumab compared to treatment with a standard of care therapy. The study will compare which treatment resulted in longer time before progression of the RCC. Patients will be treated and followed for progression of their disease on average for up to 6 months.

Metastatic Renal Cell Carcinoma

NewLink Genetics Corporation115 participantsStarted Jul 2014

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +40 more locations

Transvenous Lead Removal Post-Market Clinical Study

CRLX101(NLG207) in Combination With Bevacizumab for Metastatic Renal Cell Carcinoma (mRCC) Versus Standard of Care (SOC)

Find Trials by Condition in Houston

Vaccine Study for Surgically Resected Pancreatic Cancer

Immunotherapy Study for Surgically Resected Pancreatic Cancer

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

Non-invasive Buttock Lifting Induced by Magnetic Device - Multicentric Study

Simultaneous Integrated Boost (SIB) in Esophageal Cancer

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

Community Central Line Infection Prevention Trial

Study in Participants With Acute Migraines Headaches

ACT for CP Individual Patient Expanded Access IND Protocol

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas

Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)

Neurologic Complications in Spinal Deformity Surgery - Extension

Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients

Study Comparing OsseoSpeed™ Implants of Two Different Lengths in the Upper and Lower Posterior Jaw